Attempts have been made to produce a subunit influenza vaccine containing haemagglutinin and neuraminidase but free of lipid and nucleic acid.
Introduction
Influenza viruses are readily disintegrated into their component subunits by treatment with detergents or organic solvents but it is difficult to separate the subunits because on removal of the disintegrating agent the subunits tend to re-aggregate, especially if the preparations are of high concentration. During studies of this re-aggregation (Almeida & Hoyle, 1972) observations were made which suggested the possibility of producing by simple methods a product which contained haemagglutinin and neuraminidase but little or no lipid or nucleic acid. Such a product might make an ideal subunit vaccine.
Methods and results
Three fractionation procedures have been studied. In each case the starting material was a virus preparation purified by two cycles of adsorptionelution from red blood cells followed by differential centrifugation. The final deposited virus was suspended in phosphate buffered saline to a concentration of about 1% by volume.
In most experiments in order to follow the distribution of lipid and nucleic acid during fractionation a small amount of virus labelled with 32P was added to the stock virus. Some mechanical losses of interface protein occurred during the processing but over a series of experiments mean recoveries of 90°4 were obtained. The material was highly aggregated and serological titres were low, but neuraminidase activity was high suggesting that the proteins were not seriously damaged.
Disintegration with n-butanol
Purified virus concentrates were diluted 1:10 with buffer pH 6-5 and shaken with an equal volume of n-butanol. On centrifugation a layer of insoluble protein collected at the interface. Butanol and aqueous phases were removed and the interface material resuspended in buffer and cleared of butanol by three extractions with ether.
Results depended on the strain of virus used. In all cases the virus lipid was extracted by the butanol.
With A1 strains and some strains of virus A in which haemagglutinin and neuraminidase appear to be closely linked, both agents were precipitated and only the RNP (S antigen) remained in the aqueous phase. Serological and radioactive tracer studies showed that 90%/ of the total virus RNP antigen could be recovered. With A2 strains in which haemagglutinin and neuraminidase are present as separate subunits most ofthe neuraminidase appeared in the aqueous phase along with the RNP antigen.
The interface material consisting mainly ofhaemagglutinin was highly aggregated and difficult to resuspend. Serological titres were low or negative and tracer studies indicated the presence of about 10%0 of the original RNA and lipid.
Discussion
The attempt to produce a subunit influenza vaccine containing haemagglutinin and neuraminidase but free from lipid and RNA has not been entirely successful, but significant reduction in lipid and RNA content without great loss of protein can be obtained and the methods are undergoing further study. The products are being tested for immunogenic potency and preliminary results indicate that they do have protective value.
The disintegration of A1 strains of virus with nbutanol has proved of value as a very simple method of producing pure S antigen for use in serological diagnosis.
I regret to announce that, since the writing of this paper, work on this project has been interrupted by the sudden death of Dr Hoyle. I should like to take this opportunity to express the degree of privilege I felt of working so closely with so eminent a virologist as Dr Hoyle. S.M.B. 
